Company research
BIOMERICA INC
CIK 73290Updated Oct 19, 2026
SecurityBMRA · NASDAQ · equity
BMRA price & chart
Loading TradingView…
NASDAQ:BMRA on TradingView ↗In the news
Biomerica Announces $2.23 Million Financing ↗
Recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 4,878,000Source | 7,376,000Source | 10,342,000Source | 6,034,000Source | 7,274,000Source | 11,831,000Source | 6,854,000Source | 7,870,000Source | 6,759,000Source | 5,945,000Source | 9,254,000Source | 14,454,000Source |
| Property, Plant and Equipment, NetUSD | 91,000Source | 151,000Source | 194,000Source | 105,000Source | 167,000Source | 210,000Source | 120,000Source | 184,000Source | 78,000Source | 135,000Source | 201,000Source | 213,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 231,000Source | 234,000Source | 216,000Source | 219,000Source | 236,000Source | 204,000Source | 223,000Source | 207,000Source | 209,000Source | 228,000Source | 212,000Source | 165,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,336,000Source | 3,058,000Source | 5,319,000Source | 2,543,000Source | 2,372,000Source | 7,134,000Source | 3,053,000Source | 2,820,000Source | 1,308,000Source | 2,399,000Source | 4,170,000Source | 9,719,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 941,000Source | 1,268,000Source | 1,130,000Source | 947,000Source | 1,326,000Source | 1,067,000Source | 1,205,000Source | 1,551,000Source | 785,000Source | 731,000Source | 947,000Source | 722,000Source |
| Inventory, NetUSD | 1,645,000Source | 1,655,000Source | 2,129,000Source | 1,524,000Source | 1,789,000Source | 1,841,000Source | 1,473,000Source | 1,942,000Source | 1,707,000Source | 1,490,000Source | 2,376,000Source | 2,056,000Source |
| Assets, CurrentUSD | 4,123,000Source | 6,204,000Source | 8,846,000Source | 5,191,000Source | 5,945,000Source | 10,265,000Source | 5,899,000Source | 6,445,000Source | 4,016,000Source | 4,875,000Source | 7,731,000Source | 12,797,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 201,000Source | 223,000Source | 268,000Source | 177,000Source | 458,000Source | 223,000Source | 168,000Source | 132,000Source | 216,000Source | 255,000Source | 238,000Source | 300,000Source |
| Operating Lease, Right-of-Use AssetUSD | 179,000Source | 509,000Source | 817,000Source | 264,000Source | 588,000Source | 891,000Source | 347,000Source | 666,000Source | 1,873,000Source | 429,000Source | 742,000Source | 1,035,000Source |
| Other Assets, NoncurrentUSD | 89,000Source | 113,000Source | 104,000Source | 90,000Source | 173,000Source | 96,000Source | 100,000Source | 203,000Source | 83,000Source | 113,000Source | 203,000Source | 79,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,561,000Source | 1,842,000Source | 2,534,000Source | 1,599,000Source | 2,160,000Source | 2,448,000Source | 1,699,000Source | 2,524,000Source | 4,129,000Source | 1,840,000Source | 2,663,000Source | 2,730,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 242,000Source | 1,629,000Source | 1,346,000Source | 236,000Source | 1,467,000Source | 1,346,000Source | 225,000Source | 1,346,000Source | 255,000Source | 203,000Source | 1,346,000Source | 1,346,000Source |
| Additional Paid in CapitalUSD | 58,976,000Source | 55,642,000Source | 53,338,000Source | 58,788,000Source | 54,220,000Source | 52,997,000Source | 58,198,000Source | 53,619,000Source | 59,426,000Source | 57,175,000Source | 53,542,000Source | 52,705,000Source |
| Retained Earnings (Accumulated Deficit)USD | -55,798,000Source | -51,624,000Source | -46,774,000Source | -54,486,000Source | -50,461,000Source | -44,856,000Source | -53,166,000Source | -49,511,000Source | -56,943,000Source | -53,168,000Source | -48,195,000Source | -42,217,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -103,000Source | -113,000Source | -102,000Source | -103,000Source | -112,000Source | -104,000Source | -102,000Source | -108,000Source | -108,000Source | -105,000Source | -102,000Source | -110,000Source |
| Stockholders' Equity Attributable to ParentUSD | 3,317,000Source | 5,534,000Source | 7,808,000Source | 4,435,000Source | 5,114,000Source | 9,383,000Source | 5,155,000Source | 5,346,000Source | 2,630,000Source | 4,105,000Source | 6,591,000Source | 11,724,000Source |
| Liabilities and EquityUSD | 4,878,000Source | 7,376,000Source | 10,342,000Source | 6,034,000Source | 7,274,000Source | 11,831,000Source | 6,854,000Source | 7,870,000Source | 6,759,000Source | 5,945,000Source | 9,254,000Source | 14,454,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 1,561,000Source | 1,649,000Source | 1,991,000Source | 1,599,000Source | 1,876,000Source | 1,822,000Source | 1,693,000Source | 2,151,000Source | 2,481,000Source | 1,740,000Source | 2,204,000Source | 1,945,000Source |
| Operating Lease, Liability, CurrentUSD | 193,000Source | 350,000Source | 319,000Source | 284,000Source | 342,000Source | 311,000Source | 367,000Source | 334,000Source | 235,000Source | 358,000Source | 326,000Source | 297,000Source |
| Accounts Payable, CurrentUSD | — | — | — | — | — | — | — | — | 377,000Source | 295,000Source | 288,000Source | 344,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | 193,000Source | 543,000Source | — | 284,000Source | 626,000Source | 6,000Source | 373,000Source | 1,648,000Source | 100,000Source | 459,000Source | 785,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | — | — | — | — | — | — | — | — | 794,000Source | 377,000Source | 850,000Source | 548,000Source |
cash flow · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 20,000Source | 21,000Source | 77,000Source | 87,000Source | 81,000Source | 84,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 133,000Source | 77,000Source | 476,000Source | 460,000Source | 837,000Source | 1,185,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 512,000Source | 616,000Source | 66,000Source | -209,000Source | 215,000Source | 291,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -10,000Source | -429,000Source | 140,000Source | -882,000Source | 115,000Source | -534,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -268,000Source | -1,344,000Source | -3,421,000Source | -3,841,000Source | -5,361,000Source | -5,474,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | -1,000Source | -37,000Source | -115,000Source | -78,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | — | — | 51,000Source | 64,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 920,000Source | — | 2,334,000Source | 2,111,000Source | -81,000Source | 9,390,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 654,000Source | -1,350,000Source | -1,091,000Source | -1,770,000Source | -5,549,000Source | 3,802,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | 3,000Source | 4,000Source | 22,000Source | 10,000Source | 41,000Source | 51,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 58,000Source | 91,000Source | 72,000Source | 155,000Source | 74,000Source | 77,000Source | — | 460,000Source | 837,000Source | 1,185,000Source |
| Amortization of Intangible AssetsUSD | — | — | 6,000Source | 5,000Source | 5,000Source | 4,000Source | 5,000Source | 4,000Source | 20,000Source | 21,000Source | 18,000Source | 18,000Source |
| General and Administrative ExpenseUSD | — | — | 661,000Source | 686,000Source | 769,000Source | 739,000Source | — | — | 3,229,000Source | 2,984,000Source | — | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | 0Source | 0Source | 0Source | — | 0Source | — |
| Income Tax Expense (Benefit)USD | — | — | 8,000Source | -4,000Source | 5,000Source | -3,000Source | 3,000Source | 4,000Source | 23,000Source | 1,000Source | 42,000Source | 51,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,312,000Source | -1,163,000Source | -1,320,000Source | -950,000Source | 2,000Source | -1,316,000Source | -3,775,000Source | -4,973,000Source | -5,978,000Source | -7,140,000Source |
| Nonoperating Income (Expense)USD | — | — | -6,000Source | 43,000Source | 58,000Source | 40,000Source | 1,123,000Source | 56,000Source | 1,568,000Source | 165,000Source | 431,000Source | 134,000Source |
| Operating ExpensesUSD | — | — | 1,254,000Source | 1,229,000Source | 1,424,000Source | 1,430,000Source | 1,542,000Source | 1,657,000Source | 5,682,000Source | 5,635,000Source | 6,978,000Source | 7,669,000Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | — | — | — | 81,000Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 939,000Source | — | 1,874,000Source | 2,143,000Source | — | 10,014,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | 15,000Source | — | 81,000Source |
| Stock or Unit Option Plan ExpenseUSD | — | — | — | — | — | — | — | — | 237,000Source | — | — | — |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | 335,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | — | —Source | — | — | — | — | — | — | — | — |
| Other Nonoperating Income (Expense) | — | — | —Source | —Source | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 987,000Source | 1,119,000Source | 1,210,000Source | 1,636,000Source | 1,380,000Source | 1,807,000Source | 4,453,000Source | 5,311,000Source | 5,415,000Source | 5,339,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | — | — | 1,076,000Source | 1,012,000Source | 1,231,000Source | 1,173,000Source | 1,330,000Source | 1,360,000Source | 4,894,000Source | 4,612,000Source | 5,487,000Source | 6,085,000Source |
| Operating Income (Loss)USD | — | — | -1,298,000Source | -1,210,000Source | -1,373,000Source | -993,000Source | -1,118,000Source | -1,368,000Source | -5,320,000Source | -5,137,000Source | -6,367,000Source | -7,223,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -1,304,000Source | -1,167,000Source | -1,315,000Source | -953,000Source | 5,000Source | -1,312,000Source | -3,752,000Source | -4,972,000Source | -5,936,000Source | -7,089,000Source |
| Income Tax Expense (Benefit)USD | — | — | 8,000Source | -4,000Source | 5,000Source | -3,000Source | 3,000Source | 4,000Source | 23,000Source | 1,000Source | 42,000Source | 51,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,312,000Source | -1,163,000Source | -1,320,000Source | -950,000Source | 2,000Source | -1,316,000Source | -3,775,000Source | -4,973,000Source | -5,978,000Source | -7,140,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.44Source | -0.48Source | -0.45Source | -0.06Source | 0Source | -0.63Source | -1.3Source | -2.16Source | -0.36Source | -0.5Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.44Source | -0.48Source | -0.45Source | -0.06Source | 0Source | -0.63Source | -1.3Source | -2.16Source | -0.36Source | -0.5Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 3,010,308Source | 2,398,285Source | 2,908,164Source | 2,140,179Source | 2,638,699Source | 2,103,154Source | 2,914,923Source | 2,297,057Source | 16,821,646Source | 14,154,269Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 3,010,308Source | 2,398,285Source | 2,908,164Source | 2,140,179Source | 2,638,699Source | 2,103,154Source | 2,914,923Source | 2,297,057Source | 16,821,646Source | 14,154,269Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 6,000Source | 5,000Source | 5,000Source | 4,000Source | 5,000Source | 4,000Source | 20,000Source | 21,000Source | 18,000Source | 18,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 23,000Source | -1,000Source | -42,000Source | -51,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 20,000Source | 21,000Source | 77,000Source | 87,000Source | 81,000Source | — |
| General and Administrative ExpenseUSD | — | — | 661,000Source | 686,000Source | 769,000Source | 739,000Source | — | — | 3,229,000Source | 2,984,000Source | — | — |
| Gross ProfitUSD | — | — | -44,000Source | 19,000Source | 51,000Source | 437,000Source | 424,000Source | 289,000Source | 362,000Source | 498,000Source | 611,000Source | 446,000Source |
| Nonoperating Income (Expense)USD | — | — | -6,000Source | 43,000Source | 58,000Source | 40,000Source | 1,123,000Source | 56,000Source | 1,568,000Source | 165,000Source | 431,000Source | 134,000Source |
| Operating ExpensesUSD | — | — | 1,254,000Source | 1,229,000Source | 1,424,000Source | 1,430,000Source | 1,542,000Source | 1,657,000Source | 5,682,000Source | 5,635,000Source | 6,978,000Source | 7,669,000Source |
| Research and Development ExpenseUSD | — | — | 178,000Source | 217,000Source | 193,000Source | 257,000Source | 212,000Source | 297,000Source | 788,000Source | 1,023,000Source | 1,491,000Source | 1,584,000Source |
| Selling and Marketing ExpenseUSD | — | — | 415,000Source | 326,000Source | 462,000Source | 434,000Source | 1,330,000Source | 1,360,000Source | 1,665,000Source | 1,628,000Source | — | — |
| Other Nonoperating Income (Expense) | — | — | —Source | —Source | — | — | — | — | — | — | — | — |
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | — | —Source | — | — | — | — | — | — | — | — |
Offerings
Registration 333-299120
Registration 333-299133
Filing attachments
ex4-2.htm · 10-K/A · 2026-09-28
Exhibit 4.2 DESCRIPTION OF CAPITAL STOCK The following is a summary of all material characteristics of the capital stock of Biomerica, Inc. as set forth in our First Amended and Restated Certificate of Incorporation (our “ Charter ”), Amended and Restated Bylaws (our “ Bylaws ”), Series A Certificate of Designation, as corrected (the “ Certificate of Designation ”), and certain provisions of the General Corporation Law of the State of Delaware (the “ DGCL ”). The summary does not purport to be…
Read attachment ↗ex107.htm · S-3 · 2026-09-24
Calculation of Filing Fee Tables S-3 BIOMERICA INC ──────────────────────────────────── Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable ─────────────────────────────────────────────────────────────────────────────── Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregat…
Read attachment ↗ex4-4.htm · S-3 · 2026-09-24
Exhibit 4.4 BIOMERICA, INC. Issuer AND as Trustee INDENTURE Dated as of, 20 Debt Securities CROSS-REFERENCE TABLE(1) SECTION SECTION(S) OF OF TRUST INDENTURE INDENTURE ACT OF 1939, AS AMENDED ─────────────────────────────────────── 310(b) 7.8 311(a) 7.13 311(b) 7.13 312(a) 5.2(a) 312(b) 5.2(b) 312(c) …
Read attachment ↗ex107.htm · S-3 · 2026-09-24
Calculation of Filing Fee Tables S-3 BIOMERICA INC ──────────────────────────────────── Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable ─────────────────────────────────────────────────────────────────────────────── Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price …
Read attachment ↗ex-107.htm · S-8 · 2026-02-27
Calculation of Filing Fee Tables S-8 BIOMERICA INC ──────────────────────────────────── Table 1: Newly Registered Securities ──────────────────────────────────────── Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registra…
Read attachment ↗ex99-1.htm · 8-K · 2025-10-08
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 NEWS - For Immediate Release Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors Brings decades of leadership in laboratory testing, clinical diagnostics, payor strategy and sales growth Extensive track record in commercializing advanced laboratory testing and insurer strategies IRVINE, CA - October 8, 2025 - Biomerica Inc. (NASDAQ: BMRA), a global provider of advanced diagnostic solutions, today an…
Read attachment ↗